Octave Presents Data at the CMSC 2022 Annual Meeting Showing its Multiple Sclerosis Disease Activity Biomarker Test Produces Clinical Practice Population Insights
Company’s multivariate blood-based test can serve as a quantitative and objective tool to evaluate an individual patient’s level of disease activity as well as overall disease activity of a clinic’s population MENLO PARK, Calif.–(BUSINESS WIRE)–Octave, the developer of a fully-integrated precision care solution built to deliver comprehensive insights that bring scientific clarity to multiple sclerosis … [Read more…]
